Skip to content
DataLookout
Menu

Senhwa Biosciences, Inc. clinical trial pipeline

Get alerts when Senhwa Biosciences, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: CX-5461 · Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation Enrollment closed, study ongoing Senhwa Biosciences, Inc.Phase 1 NCT04890613
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 1
1

Disease areas by active trials

Get alerts when Senhwa Biosciences, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free